Dr. Shankaran is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
825 Eastlake Ave E
Seattle, WA 98109Phone+1 206-288-7456
Summary
- I am a medical oncologist and specialize in caring for patients with gastrointestinal malignancies, with a particular focus on cancers of the esophagus and stomach. In addition to providing my patients access to the latest scientific data and clinical trials, I believe in providing my patients and their families with the knowledge, perspective, compassion, and resources to navigate their illness and treatment course with self-assurance and dignity.
Education & Training
University of WashingtonMasters, Pharmaceutical Outcomes Research & Policy, 2012
McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2006 - 2009
Jesse Brown VA Medical CenterFellowship, Veterans Administration Health Services Research and Development Fellowship, 2009
University of MichiganResidency, Internal Medicine, 2002 - 2005
University of Michigan Medical SchoolClass of 2002- Dartmouth CollegeBachelor of Arts, Philosophy, Magna Cum Laude, 1998
Certifications & Licensure
WA State Medical License 2009 - 2026
IL State Medical License 2005 - 2011
MI State Medical License 2002 - 2005- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Puget Sound Business Journal ‘40 Under 40’ Award Puget Sound Business Journal, 2014
- Career Development Award Conquer Cancer Foundation, American Society of Clinical Oncology, 2013
- Endowed Prize in Health Policy and Economics Pharmaceutical Outcomes Research & Policy Program, University of Washington, 2012
- Join now to see all
Clinical Trials
- S1417CD Financial Impact Assessment Tool in Patients With Metastatic Colorectal Cancer Start of enrollment: 2016 Jun 22
- An Investigational Immuno-therapy Study of Nivolumab or Placebo in Participants With Resected Esophageal or Gastroesophageal Junction Cancer Start of enrollment: 2016 Jul 14
- Financial Navigation Program Intervention in Supporting Patients With Solid Tumors and Their Caregivers Start of enrollment: 2017 Nov 15
- Join now to see all
Publications & Presentations
PubMed
- 83 citationsAn International Collaborative Standardizing a Comprehensive Patient-Centered Outcomes Measurement Set for Colorectal Cancer.Jessica A. Zerillo, Maartje Gisele Schouwenburg, Annelotte C. M. van Bommel, Caleb Stowell, Jacob Lippa
JAMA Oncology. 2017-05-01 - 105 citationsNavigating financial toxicity in patients with cancer: A multidisciplinary management approach.Grace L Smith, Matthew P Banegas, Chiara Acquati, Shine Chang, Fumiko Chino
CA. 2022-09-01 - 1655 citationsIFN- γ –related mRNA profile predicts clinical response to PD-1 blockadeMark Ayers, Jared Lunceford, Michael Nebozhyn, Erin Murphy, Andrey Loboda
The Journal of Clinical Investigation. 2017-08-01
Lectures
- Real-world outcomes of first-line U.S. patients with unresectable advanced or metastatic gastroesophageal adenocarcinoma by primary tumor location.ASCO Gastrointestinal Cancers Symposium - San Francisco, CA - 1/23/2020
- A Multicenter Phase 2 Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other Solid Tumors2019 ASCO Annual Meeting - 6/1/2019
Press Mentions
JCO After Hours: A Discussion with Veena Shankaran and Scott RamseyApril 1st, 2022- Even if Insured, People with Advanced Cancer Often Face Financial ProblemsJanuary 26th, 2022
- Major Financial Hardship Prevalent in Metastatic Colorectal CancerJanuary 7th, 2022
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
